Aurobindo Pharma submits ANDA for Adapalene and Benzoyl Peroxide
Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for a combination of Adapalene and Benzoyl Peroxide.
Asset / Drug
Drug and asset intelligence for Adapalene with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.